Answers are grounded in this paper and cite their sources.
Sickle cell disease is characterized by a very heterogeneous clinical course among patients with the same mutations for sickle cell hemoglobin (HbS). Sickle cell anemia (SCA) is a hereditary hemoglobinopathy caused by the homozygosity of a point mutation in the beta-globin gene, which leads to the substitution of glutamic acid for valine in the sixth position.
No takes yet. Share an insight, caveat, or question.
Jonathan et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: